Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
27/05/2026 07:30
BRIEF-Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip' May 27 (Reuters) - Scope Fluidics SA SCPP.WA:
BACTEROMIC GRANTED U.S. PATENT 'MICROFLUIDIC CHIP'
PATENT GRANTS BACTEROMIC EXCLUSIVE U.S. COMMERCIAL RIGHTS FOR MICROFLUIDIC SYSTEMS AND METHODS
BACTEROMIC SEEKS TO EXTEND MICROFLUIDIC SYSTEM PATENT PROTECTION TO EUROPE AND CHINA
Source text: ID:nEM3xD4zRa
Further company coverage: SCPP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys